BIOTECHNOLOGY INNOVATION ORGANIZATIONPub 78
Pub 78
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$170,089,094
Investments
50%
Cash & Equivalents
21%
Other Assets
13%
Property, Plant, & Equipment (net)
9%
Prepaid Expenses
3%
Receivables (Non-Related)
3%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$76,918,293
Other Liabilities
60%
Deferred Revenue
25%
Payables & Accruals
15%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$32,346,821
$35,818,032
+11%
Receivables (Non-Related)
$5,398,766
$5,248,657
-3%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$4,097,309
$5,517,200
+35%
Investments
$80,707,801
$85,815,523
+6%
Property, Plant, & Equipment (net)
$12,905,261
$15,928,289
+23%
Other Assets
$21,183,389
$21,761,393
+3%
Total Assets
$156,639,347
$170,089,094
+9%
Liabilities
2023
2024
Change
Payables & Accruals
$12,067,134
$11,349,725
-6%
Grants Payable
-
-
-
Deferred Revenue
$21,531,353
$19,408,585
-10%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$45,680,833
$46,159,983
+1%
Total Liabilities
$79,279,320
$76,918,293
-3%
Net assets
2023
2024
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$77,360,027
$93,170,801
+20%
Net assets
2023
2024
Change
Net assets
+$77,360,027
+$93,170,801
+20%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)